The CEO of obesity drugmaker Novo Nordisk and heads of other Danish companies met on Thursday with Denmark's Prime Minister Mette Frederiksen to discuss preparations for a ...

Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group said on Thursday after business leaders, including CEO ...

No one has ever known so much about healthy eating and been less successful at following her own advice.

Specialty drugs remain the leading factor in spending, even though they represent a small fraction of overall utilization." ...

While much has changed in the world of health and medicine over the years, the sensible advice of Dr. Stephen Prescott stands ...

As we embark on 2025, the health care industry, providers and patients should be prepared for a lot of innovation, and not a ...

Each year we dedicate the final issue of Science News to reviewing the big stories in science, technology and medicine. And each year, I marvel at the many ...

Even the most iconic brand occasionally finds itself at a crossroads. A strong identity can keep you relevant for decades, ...

As well as the ability to shrink waistlines, Emma Ann Hughes unpicks how weight loss jabs have the power to transform the ...

However, a third drug also FDA-approved for weight loss, liraglutide (Saxenda), didn’t work as well as the others, ...

Ozempic was originally approved to treat people with Type 2 diabetes, but demand has surged because of the drug’s weight-loss ...